Acute Pain Global Clinical Trials Review, H1, 2017

GlobalData
343 Pages - GLDATA60411
$2,500.00

Summary

GlobalData's clinical trial report, “Acute Pain Global Clinical Trials Review, H1, 2017" provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Mallinckrodt Plc
Pfizer Inc
Grunenthal GmbH
Johnson & Johnson
Trevena Inc
Merck & Co Inc
AcelRx Pharmaceuticals Inc
Lotus Clinical Research LLC
Mundipharma International Ltd
Cara Therapeutics Inc

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Acute Pain Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Acute Pain 37
Feb 21, 2017: Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain 37
Feb 13, 2017: AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA for Use in Burn Victims with Moderate-to-Severe Acute Pain 38
Jan 04, 2017: Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain 39
Dec 06, 2016: AcelRx Pharmaceuticals Reports on ARX-04 Market and Landscape Presented at Analyst & Investor Event 39
Nov 29, 2016: KemPharm Receives Clearance from FDA to Initiate Clinical Program for KP201/IR, a Single-Entity Benzhydrocodone HCl Immediate Release Abuse-Deterrent Prodrug for the Treatment of Acute Pain 40
Clinical Trial Profile Snapshots 41
Appendix 340
Abbreviations 340
Definitions 340
Research Methodology 341
Secondary Research 341
About GlobalData 342
Contact Us 342
Disclaimer 342
Source 343

List of Tables
Acute Pain Therapeutics, Global, Clinical Trials by Region, 2017* 5
Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Acute Pain Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13
Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Acute Pain Therapeutics, Global, Clinical Trials by Phase, 2017* 25
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31
Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36

List of Figures
Acute Pain Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Acute Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13
Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 20
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Acute Pain Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31
Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
GlobalData Methodology 341

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports